Biogen Idec Inc. (BIIB)
-NasdaqGS | Prev Close: | 244.92 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 256.64 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 21-Oct-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 134.00 - 248.95 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,129,630 |
|---|
| Market Cap: | 58.21B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Cramer: Market opportunities haven't vanishedat CNBC(Tue, Oct 1)
- New Data Analyses Show Significant Clinical and MRI Improvements with PLEGRIDY™ (Peginterferon Beta-1a)Business Wire(Tue, Oct 1)
- Biogen, Isis Pharma And The Attraction Of The Orphan Drug Businessat Seeking Alpha(Sun, Sep 29)
- At Biogen, Researchers Define What Success Looks Likeat Investor's Business Daily(Fri, Sep 27)
- What a Gamed Marketat TheStreet(Fri, Sep 27)
- Jim Cramer: Don't Read This, Herbat TheStreet(Fri, Sep 27)
- Jim Cramer: Buy Amazon, CBS, and These 2 Biotech Stocksat Wall St. Cheat Sheet(Fri, Sep 27)
- Cramer's Mad Money - 10 Stocks Money Managers Will Be Buying (9/26/13)at Seeking Alpha(Fri, Sep 27)
- Jim Cramer's Top Stock Picks: BIIB CELG REGN GILD FMI FUEL DNKN XECat TheStreet(Fri, Sep 27)
- [video] 10 stocks the market has 'anointed'at CNBC(Thu, Sep 26)
- Pharmacyclics Hits New High As Bulls Launch Coverageat Investor's Business Daily(Thu, Sep 26)
- Why Is This Large Biotech Company a Sound Investment?at Motley Fool(Thu, Sep 26)
- Agios Pharma adds Biogen CFO Clancy to boardAP(Thu, Sep 26)
- [$$] Obamacare Will Boost These 2 Stocksat Barrons.com(Wed, Sep 25)
- Baxter Plunges 6% on JPMorgan's Stealth Downgradeat Barrons.com(Wed, Sep 25)
Key Statistics
| Forward P/E (1 yr): | 22.31 |
|---|
| P/S (ttm): | 9.80 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 8.59 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 2.10 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 1.46 |
|---|
Business Summary
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally.
View More